TY - JOUR
T1 - High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial
JO - The Lancet Oncology
PY - 2014/01/01
AU - Cook G
AU - Parrish C
AU - O'Connor S
AU - Williams C
AU - Brown JM
AU - Cairns DA
AU - Fletcher M
AU - Chalmers A
AU - Cavenagh J
AU - Snowden JA
AU - Ashcroft AJ et al
ED -
DO - DOI: 10.1016/S1470-2045(14)70245-1
Y2 - 2025/06/23
ER -